title: Bortezomib/bendamustine/dexamethasone induced good PR in refractory relapse post auto-SCT with constitutive RAS activation due to V600E BRAF mutation.
authors.affiliation: Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
authors.forename: C S
authors.initials: CS
authors.lastname: Chim
authors.affiliation: Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
authors.forename: K Y
authors.initials: KY
authors.lastname: Wong
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000069461:Bendamustine Hydrochloride; D001897:Boronic Acids / Q000008:administration & dosage*; D000069286:Bortezomib; D003907:Dexamethasone / Q000008:administration & dosage*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007621:Karyotyping; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000628:therapy*; D009154:Mutation; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D011719:Pyrazines / Q000008:administration & dosage*; D012008:Recurrence; D015398:Signal Transduction; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D018631:ras Proteins / Q000235:genetics
chemical_list: D018906:Antineoplastic Agents, Alkylating; D001897:Boronic Acids; D007074:Immunoglobulin G; D009588:Nitrogen Mustard Compounds; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone; D000069461:Bendamustine Hydrochloride; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D018631:ras Proteins